Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-18-009820

Options or other derivatives

  • Chief Medical Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Faleck Herbert J Chief Medical Officer 2018-03-01 Grant or award · Stock Option (Right To Purchase) +90,000 90,000 D: show line 1 in the form
Loading xslF345X03/form4.xml…